How drugs act. Drugs in angina and myocardial infarction
Smith, S.
Nursing Times 83(22): 52-54
1987
ISSN/ISBN: 0954-7762 PMID: 3648757 Document Number: 287893
Document emailed within 1 workday
Related Documents
Zangerle, R.; Sarcletti, M. 2007: Antiretroviral drugs and the risk of myocardial infarction New England Journal of Medicine 357(7): 715Reikvam, A. 1996: Use of thrombolytic agents and other drugs in acute myocardial infarction Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(14): 1671-1674
Reddy, D.S. 1998: Newer thrombolytic drugs for acute myocardial infarction Indian Journal of Experimental Biology 36(1): 1-15
Lazarczyk-Kedzia, E.; Krzemińska-Pakuła, M. 1991: Non-Q wave myocardial infarction. Recurrent myocardial infarction, unstable angina and arrhythmia in 8-year observation Kardiologia Polska 34(5): 271-276; Discussion: 277-278
Smith, J.; Channer, K.S. 1995: Increasing prescription of drugs for secondary prevention after myocardial infarction Bmj 311(7010): 917-918
Chung, E.K. 1973: The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction Singapore Medical Journal 14(3): 205-210
Hansen, J.F.; Mellemgaard, K. 1992: Drugs for the prevention of death and recurrence after acute myocardial infarction Ugeskrift for Laeger 154(7): 397
Hovland, A.; Nielsen, E.W. 2000: Check list in the treatment of acute myocardial infarction with thrombolytics and other drugs Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(13): 1580
Moss, A.J. 1986: Current status of calcium channel blocking drugs after myocardial infarction European Heart Journal 7 Suppl A: 31-34
Cardioli, E.; Mantovani, B.A.; D'Elia, N.; Martinelli, M. 1977: Behaviour of myocardial contractility during the course of an acute infarction. Influence of coronary drugs Arzneimittel-Forschung 27(7): 1493-1498
Grasela, T.H.; Green, J.A. 1990: A nationwide survey of prescribing patterns for thrombolytic drugs in acute myocardial infarction PharmacoTherapy 10(1): 35-41
Compostella, L.; Russo, R.; Nascimben, L.; Prandoni, P.; Schivazappa, L. 1981: ST-segment trend in patients with acute myocardial infarction treated with antithrombotic drugs Giornale Italiano di Cardiologia 11(11): 1762-1774
Tubek, S. 1988: Factors controlling the effectiveness of thrombolytic drugs administered by the intravenous route in myocardial infarction Wiadomosci Lekarskie 41(14): 941-943
Beck, O.A.; Vogt, J.; Hochrein, H. 1978: The comparative hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction (comparison of propafenone and lidocaine) Zeitschrift für Kardiologie 67(1): 41-45
Chichkanov, G.G.; Bogolepov, A.K.; Matsievskiĭ, D.D. 1981: Mechanism of the effect of anti-angina drugs with adrenergic beta receptor agonist action on the collateral hemodynamics and redistribution of the blood flow in chronic myocardial ischemia Kardiologiia 21(10): 85-88
Dighero, H.; Lobo, G.; Canessa, J.; Soto, C.; Zepeda, F.; Sabarots, C. 1986: Myocardial scintigraphy with Tc 99m-pyrophosphate in patients with acute transmural myocardial infarction, non-transmural infarction and unstable angina Revista Medica de Chile 114(6): 546-551
Rakov, A.L.; Ardashev, V.N.; Krivozubov, E.F.; Chernov, S.A.; Markeev, I.I. 2002: Clinical efficacy of plasmapheresis in therapy of macrofocal myocardial infarction complicated with post-infarction angina pectoris Voenno-Meditsinskii Zhurnal 323(3): 31-33
Camilleri, J.F.; Bonnet, J.L.; Bouvier, J.L.; Levy, G.; Djiane, P.; Bory, M.; Serradimigni, A. 1988: Intravenous thrombolysis in myocardial infarction. Influence of the quality of the anticoagulation on the early recurrence rate of angina or infarction Archives des Maladies du Coeur et des Vaisseaux 81(9): 1037-1041
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826